THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China
Overview
Authors
Affiliations
Guangxi Province is located in the southwest of the People's Republic of China (PRC). The province has a population of 50.12 million with a birth rate of 13.31%. Thalassemia is a major health problem in Guangxi Province. About 20.0-25.0% of the population carries thalassemia genes, which is acknowledged to be the highest prevalence in China. National and provincial programs for thalassemia prevention and control have been introduced. Premarital screening and prenatal diagnosis (PND) for the prevention of thalassemic fetuses are available. Blood transfusions, iron chelation therapy, and stem cell transplantation are also available for transfusion-dependent thalassemic patients.
Zhang Y, Kang J, Sun W, Sun F, Gao G, Chen J Mol Genet Genomics. 2025; 300(1):29.
PMID: 40053127 DOI: 10.1007/s00438-025-02234-w.
Prevalence of thalassemia-carrier couples and fertility risk assessment.
Wu L, Luo X, Tan M, Zhang L, Luo H, Huang G Int J Hematol. 2024; 119(4):374-382.
PMID: 38411864 DOI: 10.1007/s12185-024-03722-2.
Genotype analysis of 55,281 cases of thalassemia in northern Guangxi.
Zeng D, Chen Z, Yang Y, Li J, Tian B, Mo L Am J Transl Res. 2024; 16(1):51-62.
PMID: 38322564 PMC: 10839378.
Case report: Prenatal diagnosis in the fetus of a couple with both thalassemia and deafness genes.
Li Y, Liang L, Bai J, Zheng L, Qin T Front Genet. 2023; 14:1258293.
PMID: 38146341 PMC: 10749304. DOI: 10.3389/fgene.2023.1258293.
Yuan Y, Zhou X, Deng J, Zhu Q, Peng Z, Chen L Front Genet. 2023; 14:1156071.
PMID: 36936435 PMC: 10020366. DOI: 10.3389/fgene.2023.1156071.